Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 415
Selected: 0
NCT IDTitle
NCT00003890MG98 in Treating Patients With Advanced Solid Tumors
NCT03831178Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting
NCT03624543CFI-400945 in Patients With Advanced/Metastatic Breast Cancer
NCT01075308SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer
NCT05640999Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
NCT00471432OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
NCT01830621BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma
NCT01248585Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases
NCT02225015Cancer Prevention in Women With a BRCA Mutation
NCT00006229Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer
NCT00095992SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer
NCT03548077POWERPLAY: Promoting Men's Health at Work
NCT01913093N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors
NCT00372736AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors
NCT00028015SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT02974803Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases
NCT03917082Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer
NCT02821013Duration of Anti-PD-1 Therapy in Metastatic Melanoma
NCT02003222Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
NCT00079053Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00754845Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
NCT00107250AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
NCT01526135Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma
NCT00040183OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
NCT01881022An Internet-based Psychosexual Intervention for Couples Following Treatment for Breast Cancer
NCT02740920Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker
NCT00002633Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
NCT00238316Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
NCT02436707Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
NCT03127631A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
NCT00305812Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma
NCT04442048Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure
NCT05264740Motivational Interviewing to Promote Healthy Behaviours in Young Adults
NCT00371553Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer
NCT06630273Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics
NCT00275353Effectiveness of an Individualized Symptom Education Program (ISEP)
NCT01901094Comparison of Axillary Lymph Node Dissection with Axillary Radiation for Patients with Node-Positive Breast Cancer Treated with Chemotherapy
NCT00156039Randomized Trial of Follow-up Strategies in Breast Cancer
NCT01068587MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy
NCT04136353Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
NCT00066573Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer
NCT02446405Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
NCT00162929Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)
NCT02743741Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
NCT03847649A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies
NCT06439225Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes
NCT00014209Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment
NCT01138384Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer
NCT02285816MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours
NCT00438958Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases